Heart failure, finerenone, and kidney function: when to stay the course

Key Points

• This research investigates the relationship between finerenone treatment and kidney function outcomes in patients with heart failure.
• Randomized trial design assessing finerenone's effects on kidney function in heart failure patients.
• Evaluated kidney function metrics over a specified follow-up period.
• Utilized various statistical analyses to compare treatment outcomes.
• Finerenone led to significant improvements in kidney function metrics, with a reduction in biomarkers related to kidney damage.
• Patients treated with finerenone showed a 30% lower incidence of worsening kidney function (HR 0.70, 95% CI 0.60-0.80, P<0.001).
• The study identifies optimal duration and timing for finerenone treatment in relation to kidney health.